Policy Notices

• Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs
  (NOT-OD-20-164)
  National Institutes of Health
  

• Reminder: NIH Natural Disaster Policy Hurricane Laura
  (NOT-OD-20-172)
  National Institutes of Health
  

• RESCINDED - Notice of Limited Availability of Research Non-human Primates
  (NOT-OD-20-173)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

General Notices

• Pre-Application Webinar for RFA-CA-20-040, Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)
  (NOT-CA-20-105)
  National Cancer Institute
  

• NIMHD Loan Repayment Program Technical Assistance Webinar
  (NOT-MD-20-029)
  National Institute on Minority Health and Health Disparities
  

• Reissue of Parent Research Supplements to Promote Diversity in Health-Related Research FOA in October 2020
  (NOT-OD-20-170)
  National Institutes of Health
  

• Updated Information on the Research Projects Component for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
  (NOT-OH-20-008)
  National Institute for Occupational Safety and Health
  

Notice of Changes to Funding Opportunities

• Notice of Expiration of PAR-18-923 - Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
  (NOT-AI-20-072)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Expiration of PAR-19-307 " Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)"
  (NOT-AI-20-073)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Extension of the Expiration Date for PAR-18-337 "NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08, No Independent Clinical Trials)"
  (NOT-CA-20-100)
  National Cancer Institute
  

• Notice of Extension of the Expiration Date for PAR-18-364 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)"
  (NOT-CA-20-101)
  National Cancer Institute
  

• Notice of Extension of the Expiration Date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)"
  (NOT-CA-20-102)
  National Cancer Institute
  

• Notice of Extension of the Expiration Date for PAR-18-366 "NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials)"
  (NOT-CA-20-103)
  National Cancer Institute
  

• Notice of Extension of the Expiration Date for PAR-18-367 "NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)"
  (NOT-CA-20-104)
  National Cancer Institute
  

• Notice of Change to Application Due Date for RFA-DA-21-009, "Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)"
  (NOT-DA-20-080)
  National Institute on Drug Abuse
  

• NOTICE of eligibility change for PAR-18-901: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)
  (NOT-TW-20-008)
  John E. Fogarty International Center
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  (NOT-NS-20-106)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest: Alzheimers-focused administrative supplements for NIH grants that are not focused on Alzheimers disease
  (NOT-AG-20-034)
  National Institute on Aging
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design
  (NOT-AI-20-071)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Training Modules for Creating Safe, Inclusive, and Supportive Research Environments
  (NOT-GM-20-047)
  National Institute of General Medical Sciences
  

• Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
  (NOT-HD-20-025)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Palliative Care in Heart, Lung, Blood, and Sleep Diseases
  (NOT-HL-20-737)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): Research in the Emergency Setting
  (NOT-NS-20-005)
  National Institute of Neurological Disorders and Stroke
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  

• Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)
  (NOT-NS-20-038)
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
  (PAR-20-293)
  National Institute of Mental Health
  Application Receipt Date(s): May 17, 2021, May 17, 2022, May 17, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date..
  
  

• Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed)
  (PAR-20-296)
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 18, 2021; June 20, 2022; June 19, 2023
  
  

• Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
  (PAR-20-298)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 7, 2021, December 7, 2021, April 7, 2022, December 7, 2022, April 7, 2023, December 7, 2023 by 5:00 PM local time of applicant organization.
  
  

• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
  (PAR-20-299)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Application Receipt Date(s): December 10, 2020, April 9, 2021, August 10, 2021, December 10, 2021, April 11, 2022, August 10, 2022, December 9, 2022
  
  

• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
  (PAR-20-300)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): December 10, 2020, April 9, 2021, August 10, 2021, December 10, 2021, April 11, 2022, August 10, 2022, December 9, 2022
  
  

• Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Centers (U01 Clinical Trial Required)
  (RFA-DK-20-506)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 9, 2021
  
  

• Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required)
  (RFA-DK-20-507)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 9, 2021
  
  

• NIEHS SBIR Phase IIB Validation of Sensors for Improved Environmental Exposure Assessment (R44 Clinical Trial Not Allowed)
  (RFA-ES-20-016)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): December 4, 2020